Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Chief Legal Officer & Corp Sec | September 08, 2026 | September 11, 2026 |
| Covista Inc.ATGE · Entity 3964 | SVP, CLO and Secretary | August 23, 2017 | August 25, 2017 |
| Skyward Specialty Insurance Group, Inc.SKWD · Entity 4400 | Director | May 11, 2026 | May 12, 2026 |
| XPO, Inc.XPO · Entity 3242 | Director | January 04, 2021 | January 06, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date September 08, 2026 · Filed September 11, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,238 |
Last balance in matching sequence
After 2026-09-08 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2026-09-08 · Sale · Disposed 293 · Balance 9,238 Row 2 · 2026-09-08 · Exercise / conversion · Acquired 6,833 · Balance 16,071 Row 3 · 2026-09-08 · Tax withholding · Disposed 2,769 · Balance 13,302 F1: The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock. Row 4 · 2026-09-08 · Sale · Disposed 4,064 · Balance 9,238 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.96 · Expires 2035-05-20 | Direct | 35,658 |
Reported balance
After 2026-09-08 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2026-09-08 · Exercise / conversion · Disposed 6,833 · Balance 35,658 F2: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
F2: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.
Covista Inc.
Report date August 23, 2017 · Filed August 25, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,420 |
Reported balance
After 2017-08-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-08-23 · Grant · Acquired 4,420 · Balance 4,420 F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest in four equal installments beginning on the anniversary of the transaction date. |
| Incentive Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.90 · Expires 2027-08-23 | Direct | 11,796 |
Reported balance
After 2017-08-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-23 · Grant · Acquired 11,796 · Balance 11,796 F2: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.90 · Expires 2027-08-23 | Direct | 3,129 |
Reported balance
After 2017-08-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-08-23 · Grant · Acquired 3,129 · Balance 3,129 F2: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations. |
Filing footnotes · ownership attribution and instrument terms
F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest in four equal installments beginning on the anniversary of the transaction date.
F2: This option vests at 25% per year and will be fully vested at the end of the 4th year. This option was issued in two parts - one as an incentive stock option (ISO), and the other as a non-qualified stock option (NQSO) due to the ISO limitations.
Skyward Specialty Insurance Group, Inc.
Report date May 11, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,570 |
Ending reported balance
After 2026-05-11 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-05-11 · Exercise / conversion · Acquired 1,797 · Balance 5,310 F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock. Row 2 · 2026-05-11 · Sale · Disposed 100 · Balance 5,210 F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. Row 3 · 2026-05-11 · Sale · Disposed 140 · Balance 5,070 F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. Row 4 · 2026-05-11 · Sale · Disposed 500 · Balance 4,570 F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. |
| 2025 RSU AwardSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-11 · Exercise / conversion · Disposed 1,797 · Balance 0 F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock. F3: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 7, 2026. F4: The Reporting Person elected to sell shares to cover the associated tax liability incurred due to the vesting and settlement of the RSUs reported on this Form 4.The Issuer delayed the settlement, pursuant to the terms of the RSU Award Agreement, so that the sales to cover the tax liability occurred during an open trading window. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock.
F2: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4.
F3: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 7, 2026.
F4: The Reporting Person elected to sell shares to cover the associated tax liability incurred due to the vesting and settlement of the RSUs reported on this Form 4.The Issuer delayed the settlement, pursuant to the terms of the RSU Award Agreement, so that the sales to cover the tax liability occurred during an open trading window.
XPO, Inc.
Report date January 04, 2021 · Filed January 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,604 |
Reported balance
After 2021-01-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-01-04 · Grant · Acquired 1,604 · Balance 1,604 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F2: The RSUs shall vest in full on January 3, 2022, subject to the Reporting Person's continued service as a director of the Issuer. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 2,392 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 2,392 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F3: The RSUs vested in full on January 4, 2021 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,249 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 3,249 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F4: The RSUs vested in full on January 2, 2020 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 2,071 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 2,071 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F5: The RSUs vested in full on January 2, 2019 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,970 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 3,970 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F6: The RSUs vested in full on January 3, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 2,716 |
Reported balance
Holding disclosure · report date 2021-01-04 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 2,716 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. F7: The RSUs vested in full on January 1, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock.
F2: The RSUs shall vest in full on January 3, 2022, subject to the Reporting Person's continued service as a director of the Issuer.
F3: The RSUs vested in full on January 4, 2021 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F4: The RSUs vested in full on January 2, 2020 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F5: The RSUs vested in full on January 2, 2019 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F6: The RSUs vested in full on January 3, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
F7: The RSUs vested in full on January 1, 2018 and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
GXO Logistics, Inc.
Report date May 13, 2025 · Filed May 15, 2025
Section 16 reporting ended · disclosed 2025-05-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,380 |
Reported balance
After 2025-05-13 transaction · row 1
1 source rowRow 1 · 2025-05-13 · Exercise / conversion · Acquired 3,617 · Balance 12,380 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-13 · Exercise / conversion · Disposed 3,617 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F2: The RSUs vested in full on May 13, 2025, the date of the 2025 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock.
F2: The RSUs vested in full on May 13, 2025, the date of the 2025 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2026 Filed Sep 11, 2026 20:08 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,833 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001669943-26-000021 · wk-form4a_1789157336.xml · derivative · entry 5 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,658 Underlying: Common Stock · 6,833 shares Expires 2035-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter. Read SEC document |
| September 08, 2026 Filed Sep 11, 2026 20:08 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 4,064 | $85.44 | $347,228.16 |
DisclosureSEC source: 0001669943-26-000021 · wk-form4a_1789157336.xml · nonDerivative · entry 4 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,238 Read SEC document |
| September 08, 2026 Filed Sep 11, 2026 20:08 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,769 | $86.27 | $238,881.63 |
DisclosureSEC source: 0001669943-26-000021 · wk-form4a_1789157336.xml · nonDerivative · entry 3 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,302 F1 · shares: The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock. Read SEC document |
| September 08, 2026 Filed Sep 11, 2026 20:08 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 6,833 | $34.96 | $238,881.68 |
DisclosureSEC source: 0001669943-26-000021 · wk-form4a_1789157336.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2026 Filed Sep 11, 2026 20:08 UTC Amendment | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 293 | $85.44 | $25,033.92 |
DisclosureSEC source: 0001669943-26-000021 · wk-form4a_1789157336.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,238 Read SEC document |
| September 08, 2026 Filed Sep 8, 2026 20:03 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 4,064 | $85.44 | $347,228.16 |
DisclosureSEC source: 0001669943-26-000019 · wk-form4_1788897815.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,174 Read SEC document |
| September 08, 2026 Filed Sep 8, 2026 20:03 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 293 | $85.44 | $25,033.92 |
DisclosureSEC source: 0001669943-26-000019 · wk-form4_1788897815.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,238 Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 23:10 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 18,368 | $0.00 Strike: $49.39 | $0.00 |
DisclosureSEC source: 0001669943-26-000017 · wk-form4_1781737844.xml · derivative · entry 8 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,368 shares Expires 2032-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 23:10 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001669943-26-000017 · wk-form4_1781737844.xml · derivative · entry 7 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,491 Underlying: Common Stock · 11,000 shares Expires 2035-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in two equal annual installments thereafter. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 23:10 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 4,336 | $82.14 | $356,159.04 |
DisclosureSEC source: 0001669943-26-000017 · wk-form4_1781737844.xml · nonDerivative · entry 6 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,531 Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 23:10 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 13,375 | $81.04 | $1,083,889.94 |
DisclosureSEC source: 0001669943-26-000017 · wk-form4_1781737844.xml · nonDerivative · entry 5 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,867 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 23:10 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 10,996 | $82.50 | $907,170.00 |
DisclosureSEC source: 0001669943-26-000017 · wk-form4_1781737844.xml · nonDerivative · entry 4 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,242 F2 · shares: The Reporting Person exercised a stock option to purchase 18,368 shares of the Issuer's Common Stock for $49.39 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 10,996 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 23:10 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 4,661 | $82.50 | $384,532.50 |
DisclosureSEC source: 0001669943-26-000017 · wk-form4_1781737844.xml · nonDerivative · entry 3 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,238 F1 · shares: The Reporting Person exercised a stock option to purchase 11,000 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 4,661 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 23:10 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 18,368 | $49.39 | $907,195.52 |
DisclosureSEC source: 0001669943-26-000017 · wk-form4_1781737844.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 23:10 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 11,000 | $34.96 | $384,560.00 |
DisclosureSEC source: 0001669943-26-000017 · wk-form4_1781737844.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2026 Filed May 26, 2026 21:32 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,501 | $60.00 | $150,060.00 |
DisclosureSEC source: 0001669943-26-000012 · wk-form4_1779831132.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,531 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 20, 2026 Filed May 22, 2026 23:48 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 17,453 | $0.00 Strike: $60.90 | $0.00 |
DisclosureSEC source: 0001669943-26-000010 · wk-form4_1779493717.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,453 Underlying: Common Stock · 17,453 shares Expires 2036-05-20 F2 · derivative.exercise_date: The option shares vest and become exercisable over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029. Read SEC document |
| May 20, 2026 Filed May 22, 2026 23:48 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 3,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-26-000010 · wk-form4_1779493717.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,032 F1 · shares: Represents the issuance of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs vest over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:49 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 1,028 | $57.06 | $58,657.68 |
DisclosureSEC source: 0001669943-26-000008 · wk-form4_1779310152.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,338 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 11, 2026 Filed May 12, 2026 20:49 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | Exercise / conversion2025 RSU Award · Derivative | 1,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-26-000006 · form4-05122026_080553.xml · derivative · entry 5 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,797 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 7, 2026. F4 · derivative.exercise_date: The Reporting Person elected to sell shares to cover the associated tax liability incurred due to the vesting and settlement of the RSUs reported on this Form 4.The Issuer delayed the settlement, pursuant to the terms of the RSU Award Agreement, so that the sales to cover the tax liability occurred during an open trading window. F3 · derivative.expiration_date: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 7, 2026. F4 · derivative.expiration_date: The Reporting Person elected to sell shares to cover the associated tax liability incurred due to the vesting and settlement of the RSUs reported on this Form 4.The Issuer delayed the settlement, pursuant to the terms of the RSU Award Agreement, so that the sales to cover the tax liability occurred during an open trading window. Read SEC document |
| May 11, 2026 Filed May 12, 2026 20:49 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | SaleCommon Stock | 500 | $46.35 | $23,175.00 |
DisclosureSEC source: 0001669943-26-000006 · form4-05122026_080553.xml · nonDerivative · entry 4 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,570 F2 · kind: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. Read SEC document |
| May 11, 2026 Filed May 12, 2026 20:49 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | SaleCommon Stock | 140 | $46.35 | $6,489.00 |
DisclosureSEC source: 0001669943-26-000006 · form4-05122026_080553.xml · nonDerivative · entry 3 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,070 F2 · kind: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. Read SEC document |
| May 11, 2026 Filed May 12, 2026 20:49 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | SaleCommon Stock | 100 | $46.35 | $4,635.00 |
DisclosureSEC source: 0001669943-26-000006 · form4-05122026_080553.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,210 F2 · kind: Sales to cover taxes and fees incurred in connection with the vesting and settlement of the Reporting Person's RSUs reported on this Form 4. Read SEC document |
| May 11, 2026 Filed May 12, 2026 20:49 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | Exercise / conversionCommon Stock | 1,797 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001669943-26-000006 · form4-05122026_080553.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock. Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:22 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | Grant2026 RSU Award · Derivative | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-26-000004 · form4-05082026_080518.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,334 Underlying: Common Stock · 3,334 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents the right to receive, after vesting and upon settlement, one share of Common Stock of the Issuer. F2 · derivative.exercise_date: On May 6, 2026, the Reporting Person was granted an RSU Award in the amount of 3,334 RSUs. Subject to the terms of the award agreement, this award will fully vest on the date of the Issuer's 2027 Annual Meeting of Shareholders. F2 · derivative.expiration_date: On May 6, 2026, the Reporting Person was granted an RSU Award in the amount of 3,334 RSUs. Subject to the terms of the award agreement, this award will fully vest on the date of the Issuer's 2027 Annual Meeting of Shareholders. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 22:49 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,427 | $0.00 Strike: $27.83 | $0.00 |
DisclosureSEC source: 0001669943-26-000002 · wk-form4_1772664574.xml · derivative · entry 3 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,848 Underlying: Common Stock · 12,427 shares Expires 2035-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 22:49 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 12,427 | $36.18 | $449,608.86 |
DisclosureSEC source: 0001669943-26-000002 · wk-form4_1772664574.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,366 F1 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $35.92 to $36.61 The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 22:49 UTC | Anterix Inc. ATEX · Entity 4597 | Exercise / conversionCommon Stock | 12,427 | $27.83 | $345,843.41 |
DisclosureSEC source: 0001669943-26-000002 · wk-form4_1772664574.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 18:42 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 6,564 | $21.07 | $138,303.48 |
DisclosureSEC source: 0001669943-25-000007 · wk-form4_1763577732.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,366 Read SEC document |
| May 22, 2025 Filed May 23, 2025 18:28 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,732 | $28.35 | $77,452.20 |
DisclosureSEC source: 0001304492-25-000048 · wk-form4_1748024915.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,930 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 20, 2025 Filed May 22, 2025 19:19 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 53,491 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001304492-25-000039 · wk-form4_1747941549.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,491 Underlying: Common Stock · 53,491 shares Expires 2035-05-20 F1 · derivative.exercise_date: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter. Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:33 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 1,101 | $28.42 | $31,290.42 |
DisclosureSEC source: 0001304492-25-000031 · wk-form4_1747776775.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,662 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 15, 2025 Filed May 20, 2025 21:33 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 2,320 | $28.06 | $65,099.20 |
DisclosureSEC source: 0001304492-25-000031 · wk-form4_1747776775.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,763 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:31 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 3,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001852244-25-000059 · wk-form4_1747341080.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F2 · derivative.exercise_date: The RSUs vested in full on May 13, 2025, the date of the 2025 annual meeting of stockholders. F2 · derivative.expiration_date: The RSUs vested in full on May 13, 2025, the date of the 2025 annual meeting of stockholders. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:31 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionCommon Stock | 3,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001852244-25-000059 · wk-form4_1747341080.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2025 Filed May 9, 2025 20:05 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | Exercise / conversion2024 RSU Award · Derivative | 2,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012468 · form4-05092025_040503.xml · derivative · entry 3 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the right to receive, at settlement, one share of Common Stock of the Issuer. F4 · derivative.exercise_date: On May 9, 2024, the Reporting Person was granted an RSU Award in the amount of 2,779 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 9, 2025. F4 · derivative.expiration_date: On May 9, 2024, the Reporting Person was granted an RSU Award in the amount of 2,779 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 9, 2025. Read SEC document |
| May 09, 2025 Filed May 9, 2025 20:05 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | Exercise / conversionCommon Stock | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-012468 · form4-05092025_040503.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:05 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | Grant2025 RSU Award · Derivative | 1,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012468 · form4-05092025_040503.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,797 Underlying: Common Stock · 1,797 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents the right to receive, at settlement, one share of Common Stock of the Issuer. F3 · derivative.exercise_date: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the award agreement, this award will fully vest on May 7, 2026. F3 · derivative.expiration_date: On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the award agreement, this award will fully vest on May 7, 2026. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:23 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | SaleCommon Stock | 1,000 | $50.62 | $50,615.40 |
DisclosureSEC source: 0001415889-25-007510 · form4-03102025_080342.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 734 F1 · price: Prices reported in Column 4 are weighted average prices. Shares were sold in multiple transactions at prices ranging from $50.61-$50.64, inclusive (weighted average of $50.6154). Reporting Person undertakes to provide to issuer or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth herein. Read SEC document |
| January 16, 2025 Filed Jan 21, 2025 22:27 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 37,275 | $0.00 Strike: $27.83 | $0.00 |
DisclosureSEC source: 0001304492-25-000012 · wk-form4_1737498468.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,275 Underlying: Common Stock · 37,275 shares Expires 2035-01-16 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in three equal annual installments with vesting commencing on January 16, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:06 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionRestricted Stock Units · Derivative | 1,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-25-000002 · wk-form4_1736201183.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F2 · derivative.exercise_date: The RSUs vested in full on January 2, 2025. F2 · derivative.expiration_date: The RSUs vested in full on January 2, 2025. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:06 UTC | GXO Logistics, Inc. GXO · Entity 3871 | Exercise / conversionCommon Stock | 1,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-25-000002 · wk-form4_1736201183.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2024 Filed Nov 20, 2024 21:45 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 5,547 | $33.00 | $183,051.00 |
DisclosureSEC source: 0001304492-24-000125 · wk-form4_1732139103.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,083 Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 21:57 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 30,731 | $0.00 Strike: $35.66 | $0.00 |
DisclosureSEC source: 0001304492-24-000114 · wk-form4_1728424635.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,731 Underlying: Common Stock · 30,731 shares Expires 2034-10-04 F1 · derivative.exercise_date: The option shares vest on the third anniversary of the grant date, subject to (i) the Reporting Person's continued service with the Issuer through this date and (ii) the Issuer's common stock achieving a specified price per share during the three-year period. Read SEC document |
| May 21, 2024 Filed May 23, 2024 21:06 UTC | GXO Logistics, Inc. GXO · Entity 3871 | GrantRestricted Stock Units · Derivative | 3,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001669943-24-000006 · wk-form4_1716498363.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,617 Underlying: Common Stock · 3,617 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock. F2 · derivative.exercise_date: The RSUs shall vest in full on May 21, 2025, subject to the Reporting Person's continued service as a director of GXO. F2 · derivative.expiration_date: The RSUs shall vest in full on May 21, 2025, subject to the Reporting Person's continued service as a director of GXO. Read SEC document |
| May 17, 2024 Filed May 21, 2024 18:10 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 1,166 | $33.52 | $39,084.32 |
DisclosureSEC source: 0001304492-24-000056 · wk-form4_1716315038.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,630 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 15, 2024 Filed May 18, 2024 01:58 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 4,066 | $32.72 | $133,039.52 |
DisclosureSEC source: 0001304492-24-000051 · wk-form4_1715997512.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,796 F1 · shares: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:49 UTC | Skyward Specialty Insurance Group, Inc. SKWD · Entity 4400 | Grant2024 RSU Award · Derivative | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-013014 · form4-05132024_080552.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,779 Underlying: Common Stock · 2,779 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each Restricted Stock Unit ("RSU") settles for one share of the Company's Common Stock. F1 · price: Upon vesting, each Restricted Stock Unit ("RSU") settles for one share of the Company's Common Stock. F2 · derivative.exercise_date: On May 9, 2024, the Reporting Person was granted an RSU Award in the amount of 2,779 Units. Subject to the terms of the RSU Agreement, this award will fully vest on May 9, 2025. F2 · derivative.expiration_date: On May 9, 2024, the Reporting Person was granted an RSU Award in the amount of 2,779 Units. Subject to the terms of the RSU Agreement, this award will fully vest on May 9, 2025. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 22:13 UTC | GXO Logistics, Inc. GXO · Entity 3871 | SaleCommon Stock | 13,370 | $50.00 | $668,500.00 |
DisclosureSEC source: 0001669943-24-000004 · wk-form4_1710195190.xml · nonDerivative · entry 2 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,481 F1 · shares: These shares were sold for tax and estate planning purposes. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 22:13 UTC | GXO Logistics, Inc. GXO · Entity 3871 | SaleCommon Stock | 4,737 | $50.00 | $236,850.00 |
DisclosureSEC source: 0001669943-24-000004 · wk-form4_1710195190.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,851 F1 · shares: These shares were sold for tax and estate planning purposes. F2 · balance_after: Due to a clerical error, the reporting person's Form 4 filed on January 4, 2024 inadvertently under reported the number of deferred shares delivered in connection with the vesting of restricted stock units by 10,526 shares. This Form 4 corrects such error by increasing the total amount of securities beneficially owned by the reporting person by such 10,526 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.